Golden has been acquired by ComplyAdvantage.Read about it here ⟶

EpimAb Biotherapeutics

EpimAb Biotherapeutics is a bi-specific Antibodies founded in 2015 by Chengbin Wu.

Overview Structured Data Issues Contributors Activity

epimab.com

Is a

Organization

Company

Company attributes

Industry

Biotechnology

Engineering

Technology

Biomedical engineering

Location

B2X

Founder

Number of Employees (Ranges)

11 – 500

Email Address

contact@epimab.com

Phone Number

+862161951000

Full Address

6th Floor, Building 2, Jinchuang Building, 702 Zhongke Road, Zhangjiang High-tech Park, Shanghai, 201204, China

Investors

Yanchuang Capital

Decheng Capital

3E Bioventures Capital (3E)

‌

Trend Investment Group

Oriza Seed Venture Capital

Founded Date

2015

Total Funding Amount (USD)

99,000,000

Latest Funding Round Date

June 5, 2019

Board of Directors

Victor Tong

Latest Funding Type

Series B Round

Patents Assigned (Count)

Country

China

Headquarters

Shanghai

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like EpimAb Biotherapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API